VLTO: Buyback And In-Situ Acquisition Will Support Future EPS Compounding

Analysts have trimmed their price targets on Veralto, contributing to a reduction in our fair value estimate from $114.00 to about $110.59 as they factor in slightly lower revenue growth assumptions, a modestly lower future P/E, and a higher expected profit margin.

Analyst Commentary

Recent Street research on Veralto has centered on lower price targets and a closer look at how management is using capital for buybacks and acquisitions. While the overall direction of target prices has been cautious, analysts are drawing different conclusions about how this sets up the stock in terms of execution risk and potential upside.

Bullish Takeaways

• Bullish analysts highlight the US$750m share buyback as a shareholder friendly use of capital that can support per share metrics if executed opportunistically.
• The US$422m acquisition of In-Situ is seen as a fit with Veralto's existing portfolio, which some analysts view as supportive of the company’s ability to deepen its core offerings over time.
• Some research points to Veralto as a "solid 10% compounder," which, if achieved, would justify a valuation that assumes steady execution on growth and margin goals.
• Even where targets are reduced, bullish analysts often maintain positive ratings, suggesting they still see room for upside if management delivers on its plan.

Bearish Takeaways

• Bearish analysts have reduced price targets by US$2 to US$9, reflecting more conservative assumptions on future revenue and the P/E multiple investors may be willing to pay.
• The US$422m price tag for In-Situ is described as expensive, which raises questions about the payoff period and integration risk, and whether returns on invested capital will match expectations.
• Target cuts across multiple research firms signal concern that previous expectations for growth and valuation may have been too optimistic, leaving less room for execution missteps.
• Some bearish analysts appear cautious that, despite the buyback, capital allocation between repurchases and acquisitions could limit flexibility if business conditions or deal outcomes are less favorable than expected.

What's in the News

• Veralto is actively seeking acquisitions, with management highlighting a full pipeline of M&A opportunities across Water Quality and Product Quality & Innovation (PQI). Management is emphasizing discipline on market selection, asset quality, and valuation (Key Developments).
• Management has indicated an intention to continue its M&A activity this year, while acknowledging that deal timing can be episodic and influenced by factors outside the company’s control (Key Developments).
• The board authorized a share repurchase program, allowing Veralto to buy back up to US$750m of its shares with no stated expiration. This provides an additional option for capital deployment alongside M&A (Key Developments).
• Veralto’s board approved an 18% increase to the quarterly cash dividend, setting it at US$0.13 per share, payable on January 30, 2026 to shareholders of record on December 31, 2025 (Key Developments).
• Management has framed buybacks as a complementary tool to M&A, suggesting repurchases may be used more heavily during periods when acquisition activity is lighter. Management has not indicated any change to longer term M&A aspirations (Key Developments).

Valuation Changes

• Fair Value Estimate trimmed from US$114.00 to about US$110.59, reflecting slightly more conservative assumptions.
• Discount Rate adjusted marginally from 7.13% to about 7.13%, indicating only a very small change in the required return input.
• Revenue Growth revised from 6.38% to about 5.87%, signaling a modestly lower growth assumption in the model.
• Net Profit Margin raised from 17.76% to about 18.25%, incorporating expectations for somewhat higher profitability over time.
• Future P/E moved from 30.05x to about 28.63x, implying a slightly lower valuation multiple applied to future earnings.